• Home
  • Ongoing Clinical Studies

Ongoing Clinical Studies

Filter Clinical Studies by:

Name

Physician(s)

Lung-Cancer

Name

Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice ›

Physician(s)

Troy H. Guthrie, Jr., MD

Name

PHASE III COMPARISON OF THORACIC RADIOTHERAPY REGIMENS IN PATIENTS WITH LIMITED SMALL CELL LUNG CANCER ALSO RECEIVING CISPLATIN OR CARBOPLATIN AND ETOPOSIDE ›

Physician(s)

John Vito Antonucci, MD
Michael I. Ghilezan, MD, PhD
Larry L. Kestin, MD
Kay T. Miller, MD
Frank A. Vicini, MD

Name

Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) (150kHz) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC) ›

Physician(s)

John Vito Antonucci, MD

Lymphoma

Name

A Phase 3, Randomized Study to Assess the Efficacy and Safety of Ublituximab in Combination With TGR-1202 Compared to Obinutuzumab in Combination With Chlorambucil in Patients With Chronic Lymphocytic Leukemia (CLL)  ›

Physician(s)

Troy H. Guthrie, Jr., MD

Name

Phase 1/2A Dose Escalation Study in CLL, SLL or NHL ›

Physician(s)

Troy H. Guthrie, Jr., MD

Pancreatic-Cancer

Name

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma ›

Physician(s)

Troy H. Guthrie, Jr., MD

Name

A Prospective Quality of Life Study in Metastatic Pancreatic Cancer ›

Physician(s)

Troy H. Guthrie, Jr., MD

Prostate-Cancer

Name

A Phase 3 Randomized, Placebo-controlled, Double-blind Study of JNJ-56021927 Plus Androgen Deprivation Therapy (ADT) Versus ADT in Subjects with Low-volume Metastatic Hormone-sensitive Prostate Cancer (mHSPC)  ›

Physician(s)

Constantine A. Mantz, MD

Name

A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) With or Without Intensity Modulated Radiation Therapy (IMRT) in the Treatment of Patients with Clinically Confined Prostate Adenocarcinoma ›

Physician(s)

Constantine A. Mantz, MD
Stephen F. Andrews, DO
Christopher T. Chen, MD, FACRO
Chaundré K. Cross, MD
Eduardo B. Fernandez, MD, PhD, FACRO, FASTRO
Patrick M. Francke, MD, FACRO
Brian D. Lawenda, MD
Marshal E. Lieberfarb, MD, PhD
Keith L. Miller, MD

Name

A Prospective Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC) in the United States ›

Physician(s)

John E. Sylvester, MD
Chaundré K. Cross, MD
Marc J. Guttman, DO

Back
To top